Reference Resource
Cosmetic Regulatory Compliance Hub
A practical reference for beauty brand founders navigating cosmetic regulations in Canada, the United States, and the European Union. Official portal links, side-by-side comparisons, pre-launch checklists, and plain-language explanations — all in one place.
Note: This hub is an educational reference only and does not constitute legal or regulatory advice. Regulations change frequently. Always verify requirements directly with the relevant authority or consult a qualified regulatory consultant before bringing a product to market.
Official Portals
Where to Register Your Products
Each market has a designated notification or registration portal. These are the official government systems you must use — third-party services cannot substitute for direct registration.
Canada
Health Canada
- Timing
- Notify within 10 days of first sale in Canada
- Framework
- Cosmetic Regulations (SOR/2006-120)
- Language
- English & French bilingual labelling required
- Prohibited Substances
- Hotlist — 600+ prohibited/restricted substances
United States
U.S. Food & Drug Administration (FDA)
- Timing
- Register facility + list products under MoCRA (2024)
- Framework
- FD&C Act + MoCRA (2022) + FP&L Act
- Language
- English; Spanish voluntary
- Prohibited Substances
- Prohibited Ingredients List (11 categories)
European Union
European Commission
- Timing
- Notify via CPNP before placing on EU market
- Framework
- EU Cosmetics Regulation 1223/2009
- Language
- Language of the member state where sold
- Prohibited Substances
- Annexes II–VI — 1,300+ prohibited/restricted substances
Comparison Table
Canada vs. US vs. EU — Side by Side
The three major regulatory frameworks share common principles but differ significantly in their specific requirements. Use this table to identify where your compliance gaps are before launching in a new market.
| Criterion | Canada | United States | European Union |
|---|---|---|---|
| Regulatory Framework | Cosmetic Regulations (SOR/2006-120) | FD&C Act + MoCRA (2022) | EU Regulation 1223/2009 |
| Notification Timing | Within 10 days after first sale | Pre-registration required (MoCRA) | Before placing on market |
| INCI Ingredient Listing | Required (descending order) | Required (descending order) | Required (descending order) |
| Bilingual Labelling | English & French mandatory | English only (Spanish voluntary) | Language of member state |
| Safety Assessment | Manufacturer responsibility | Manufacturer responsibility | Mandatory Cosmetic Product Safety Report (CPSR) |
| Product Information File | Not formally required | Substantiation records required | Mandatory PIF with CPSR |
| Responsible Person | Manufacturer/importer | Facility registrant | Designated Responsible Person (EU-based) |
| Prohibited Substances | Health Canada Hotlist | FDA Prohibited List (11 categories) | Annexes II–VI (1,300+ entries) |
| Fragrance Allergen Disclosure | 26 allergens (2026 rule) | Not yet mandated | 26 allergens above threshold |
| Nanomaterials | No specific nano rules yet | Voluntary guidance | Mandatory nano notification |
| Animal Testing | Not prohibited federally | Not prohibited federally | Prohibited since 2013 |
| Good Manufacturing Practice | Recommended (ISO 22716) | Required under MoCRA | Required (ISO 22716) |
Last reviewed: March 2026. Regulations change — always verify with the relevant authority.
Compliance Checklist
Pre-Launch Compliance Checklist
Use this checklist to track your compliance milestones from formulation through post-market obligations. Items are organized by phase, not by market — most apply to all three jurisdictions unless noted.
Before Formulation
- Confirm all ingredients are permitted in your target markets
- Cross-reference Health Canada Hotlist, FDA Prohibited List, and EU Annexes II–VI
- Check concentration limits for restricted actives (e.g., retinol, AHAs, hydroquinone)
- Verify nanomaterial status if using nano-sized ingredients for EU market
- Confirm fragrance allergen disclosure requirements for all markets (26 allergens in Canada from 2026)
Labelling & Claims
- Prepare bilingual (English/French) label for Canadian market
- Include INCI ingredient list in descending order of concentration
- Add net quantity, manufacturer/importer name and address
- Avoid drug claims (e.g., ‘treats’, ‘heals’, ‘cures’) — these trigger drug regulations
- Substantiate all marketing claims (e.g., ‘clinically tested’, ‘dermatologist approved’)
- Include batch code and best-before date where applicable
Pre-Market Compliance
- Complete stability testing (minimum 12-month accelerated study)
- Complete challenge/preservative efficacy testing
- Commission patch testing / HRIPT if making skin-compatibility claims
- Prepare Product Information File (PIF) for EU market
- Engage a Responsible Person if selling in the EU (must be EU-based entity)
- Notify Health Canada CNP within 10 days of first Canadian sale
- Register facility and list products in FDA MoCRA portal (US market)
- Notify CPNP before placing product on EU market
Ongoing Compliance
- Renew FDA facility registration annually (MoCRA requirement)
- Update CNP notification if formulation changes by ≥10% for any ingredient
- Monitor Health Canada Hotlist updates (published periodically)
- Monitor EU Annex updates — the EU amends Annexes II–VI regularly
- Maintain batch records and retain for minimum 3 years post-sale
- Report serious undesirable effects (SUEs) to relevant authorities within required timelines
Glossary
Key Regulatory Definitions
Regulatory language is precise. These definitions reflect how each term is used in the context of cosmetic compliance — not general usage.
Cosmetic (Canada)
A substance or mixture of substances manufactured, sold, or represented for use in cleansing, improving, or altering the complexion, skin, hair, or teeth. Does not include drugs.
Cosmetic (US/FDA)
Articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body for cleansing, beautifying, promoting attractiveness, or altering appearance.
Cosmetic (EU)
Any substance or mixture intended to be placed in contact with the external parts of the human body for the purpose of cleaning, perfuming, changing appearance, or protecting them.
INCI Name
International Nomenclature of Cosmetic Ingredients — the standardized naming system for cosmetic ingredients used on labels in all three markets.
Health Canada Hotlist
A list of substances that are prohibited or restricted for use in cosmetic products sold in Canada. Updated periodically.
Responsible Person (EU)
A legal or natural person established within the EU who ensures compliance with EU Regulation 1223/2009 for each cosmetic product placed on the EU market.
Product Information File (PIF)
A mandatory document required for all cosmetics sold in the EU, containing the product description, safety report, manufacturing method, and evidence of claimed effects.
Cosmetic Product Safety Report (CPSR)
Part A and B safety assessment required for all EU cosmetics, prepared by a qualified safety assessor. Mandatory component of the PIF.
MoCRA (US)
Modernization of Cosmetics Regulation Act of 2022 — the most significant update to US cosmetic law in 85 years. Introduced mandatory facility registration, product listing, and safety substantiation requirements.
Serious Undesirable Effect (SUE)
An undesirable effect that results in temporary or permanent functional incapacity, disability, hospitalization, congenital anomalies, or death. Must be reported to authorities in all three markets.
GMP / ISO 22716
Good Manufacturing Practice guidelines for cosmetics. Mandatory under MoCRA (US) and EU Regulation; strongly recommended by Health Canada.
Nanomaterial
An insoluble or biopersistent material with one or more external dimensions in the 1–100 nm range. Subject to specific notification requirements in the EU; voluntary guidance in the US; no specific rules yet in Canada.
2026 Updates
What Changed in 2025–2026
Fragrance Allergen Disclosure Rule
Health Canada finalized regulations requiring disclosure of 26 fragrance allergens above specified concentration thresholds on cosmetic labels. Brands must comply for products manufactured after the effective date in 2026.
MoCRA Full Implementation
The Modernization of Cosmetics Regulation Act (2022) is now fully in effect. All cosmetic facilities must be registered and products listed with the FDA. Fragrance allergen labelling rules are under development.
Annex III Restrictions Update
The EU Commission updated Annex III restrictions on several UV filters and preservatives. Brands using benzophenone-3, homosalate, and certain parabens at higher concentrations must reformulate or relabel.
Free Resource
Pre-Launch Compliance Checklist
2026 Edition
A 3-page, print-ready PDF covering all 30 regulatory requirements across Canada, the United States, and the European Union — organised into 4 actionable phases with official portal links and a legal disclaimer.
- 30 checklist items
- 4 phases in order
- Canada · USA · EU
- 2026 regulations
- Official portal links
- Print-ready PDF
PDF · 3 Pages · 2026 Edition
Formyoule™ Inc. — formyouleinc.com
Need Compliance Support?
We Handle Compliance
So You Don’t Have To
Formyoule™ Inc. manages Health Canada CNP notifications, regulatory documentation, and label compliance as part of our full-service offering. Book a free 15-minute intro call to discuss your specific markets and compliance requirements.